Cancer Biological Therapy Market By Product Type and Distribution Channel - Global Industry Analysis & Forecast to 2025
- CRY2871931
- 130 Pages
- January 2019
- Pharmaceuticals
Industry Outlook and Trend Analysis
The Cancer Biological Therapy Market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period. Biological cancer treatments make use of the immune system of the body, either indirectly or in a directly way, to battle disease or to diminish the symptoms that might be caused by some cancer therapies. It is additionally known as biotherapy or biological reaction modifiers. Interferons and monoclonal antibodies are among the most encouraging natural ways to deal with cancer treatment. Biological treatment works by boosting, stimulating, reestablishing or acting like the body's immune system response against the cells that are cancerous.
Drivers and Restraints
Major factors, for example, developing pervasiveness of cancer, constant patent expiry of cancer medications, rising effect of biosimilars and expanding request of natural and focused on medication treatments will drive the general cancer biological therapy market. As per WHO, the quantity of new malignant growth cases is anticipated to rise 70% in the coming two decades, predominantly because of expanded utilization of tobacco and liquor utilization. Nonetheless, the risk of failure in therapy, the staggering expense of medication advancement, the unfriendly impacts of cancer drug treatment, especially chemotherapy and stricter government directions will ruins the general cancer biological therapy market growth globally.
Regional Insights
Geographically, North America overwhelms a noteworthy offer of the worldwide Cancer Biological Therapy market. The North American market is trailed by Europe, Asia Pacific.
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
UK
France
Russia
Italy
Rest of Europe
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Rest of Asia-Pacific
South America
Brazil
Argentina
Columbia
Rest of South America
Middle East and Africa
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
Bristol-Myers Squibb
F. Hoffmann-La Roche AG
Merck & Co., Inc
Eli Lilly
Seattle Genetics, Inc
Amgen Inc
Celgene Corporation
Novartis International AG
GlaxoSmithKline Plc
Spectrum Pharmaceuticals, Inc
Some of the key questions answered by the report are:
What was the market size in 2014 and forecast from 2015 to 2025?
What will be the industry market growth from 2015 to 2025?
What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
What are the major segments leading the market growth and why?
Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. SWOT Analysis
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2014-2025)
4.1.2. Canada Market Status and Outlook (2014-2025)
4.1.3. Mexico Market Status and Outlook (2014-2025)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2014-2025)
4.2.2. France Market Status and Outlook (2014-2025)
4.2.3. UK Market Status and Outlook (2014-2025)
4.2.4. Russia Market Status and Outlook (2014-2025)
4.2.5. Italy Market Status and Outlook (2014-2025)
4.2.6. Rest of Europe Market Status and Outlook (2014-2025)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2014-2025)
4.3.2. Japan Market Status and Outlook (2014-2025)
4.3.3. Korea Market Status and Outlook (2014-2025)
4.3.4. India Market Status and Outlook (2014-2025)
4.3.5. Southeast Asia Market Status and Outlook (2014-2025)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2014-2025)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2014-2025)
4.4.2. Argentina Market Status and Outlook (2014-2025)
4.4.3. Columbia Market Status and Outlook (2014-2025)
4.4.4. Rest of South America Market Status and Outlook (2014-2025)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2014-2025)
4.5.2. United Arab Emirates Market Status and Outlook (2014-2025)
4.5.3. Egypt Market Status and Outlook (2014-2025)
4.5.4. Nigeria Market Status and Outlook (2014-2025)
4.5.5. South Africa Market Status and Outlook (2014-2025)
4.5.6. Turkey Market Status and Outlook (2014-2025)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2014-2025)
5. Cancer Biological Therapy Market, By Product Type
5.1. Introduction
5.2. Global Cancer Biological Therapy Revenue and Market Share by Product Type (2014-2018)
5.2.1. Global Cancer Biological Therapy Revenue and Revenue Share by Product Type (2014-2018)
5.3. Cancer growth blockers
5.3.1. Global Cancer growth blockers Revenue and Growth Rate (2014-2018)
5.4. Cytokines
5.4.1. Global Cytokines Revenue and Growth Rate (2014-2018)
5.5. Gene therapy
5.5.1. Global Gene therapy Revenue and Growth Rate (2014-2018)
5.6. Vaccines
5.6.1. Global Vaccines Revenue and Growth Rate (2014-2018)
5.7. Monoclonal antibodies
5.7.1. Global Monoclonal antibodies Revenue and Growth Rate (2014-2018)
5.8. Blood cell growth factors
5.8.1. Global Blood cell growth factors Revenue and Growth Rate (2014-2018)
6. Cancer Biological Therapy Market, By Distribution Channel
6.1. Introduction
6.2. Global Cancer Biological Therapy Revenue and Market Share by Distribution Channel (2014-2018)
6.2.1. Global Cancer Biological Therapy Revenue and Revenue Share by Distribution Channel (2014-2018)
6.3. Retail pharmacies
6.3.1. Global Retail pharmacies Revenue and Growth Rate (2014-2018)
6.4. Hospital pharmacies
6.4.1. Global Hospital pharmacies Revenue and Growth Rate (2014-2018)
6.5. Mail order pharmacies
6.5.1. Global Mail order pharmacies Revenue and Growth Rate (2014-2018)
7. Cancer Biological Therapy Market, By Region
7.1. Introduction
7.2. Global Cancer Biological Therapy Revenue and Market Share by Regions
7.2.1. Global Cancer Biological Therapy Revenue by Regions (2014-2018)
7.3. North America Cancer Biological Therapy by Countries
7.3.1. North America Cancer Biological Therapy Revenue and Growth Rate (2014-2018)
7.3.2. North America Cancer Biological Therapy Revenue (Million USD) by Countries (2014-2018)
7.3.3. United States
7.3.3.1. United States Cancer Biological Therapy Revenue (Millions USD) and Growth Rate (2014-2018)
7.3.4. Canada
7.3.4.1. Canada Cancer Biological Therapy Revenue (Millions USD) and Growth Rate (2014-2018)
7.3.5. Mexico
7.3.5.1. Mexico Cancer Biological Therapy Revenue (Millions USD) and Growth Rate (2014-2018)
7.4. Europe Cancer Biological Therapy by Countries
7.4.1. Europe Cancer Biological Therapy Revenue and Growth Rate (2014-2018)
7.4.2. Europe Cancer Biological Therapy Revenue (Million USD) by Countries (2014-2018)
7.4.3. Germany
7.4.3.1. Germany Cancer Biological Therapy Revenue (Millions USD) and Growth Rate (2014-2018)
7.4.4. France
7.4.4.1. France Cancer Biological Therapy Revenue (Millions USD) and Growth Rate (2014-2018)
7.4.5. UK
7.4.5.1. UK Cancer Biological Therapy Revenue (Millions USD) and Growth Rate (2014-2018)
7.4.6. Russia
7.4.6.1. Russia Cancer Biological Therapy Revenue (Millions USD) and Growth Rate (2014-2018)
7.4.7. Italy
7.4.7.1. Italy Cancer Biological Therapy Revenue (Millions USD) and Growth Rate (2014-2018)
7.4.8. Rest of Europe
7.4.8.1. Rest of Europe Cancer Biological Therapy Revenue (Millions USD) and Growth Rate (2014-2018)
7.5. Asia-Pacific Cancer Biological Therapy by Countries
7.5.1. Asia-Pacific Cancer Biological Therapy Revenue and Growth Rate (2014-2018)
7.5.2. Asia-Pacific Cancer Biological Therapy Revenue (Million USD) by Countries (2014-2018)
7.5.3. China
7.5.3.1. China Cancer Biological Therapy Revenue (Millions USD) and Growth Rate (2014-2018)
7.5.4. Japan
7.5.4.1. Japan Cancer Biological Therapy Revenue (Millions USD) and Growth Rate (2014-2018)
7.5.5. Korea
7.5.5.1. Korea Cancer Biological Therapy Revenue (Millions USD) and Growth Rate (2014-2018)
7.5.6. India
7.5.6.1. India Cancer Biological Therapy Revenue (Millions USD) and Growth Rate (2014-2018)
7.5.7. Southeast Asia
7.5.7.1. Southeast Asia Cancer Biological Therapy Revenue (Millions USD) and Growth Rate (2014-2018)
7.5.8. Rest of Asia-Pacific
7.5.8.1. Rest of Asia-Pacific Cancer Biological Therapy Revenue (Millions USD) and Growth Rate (2014-2018)
7.6. South America Cancer Biological Therapy by Countries
7.6.1. South America Cancer Biological Therapy Revenue and Growth Rate (2014-2018)
7.6.2. South America Cancer Biological Therapy Revenue (Million USD) by Countries (2014-2018)
7.6.3. Brazil
7.6.3.1. Brazil Cancer Biological Therapy Revenue (Millions USD) and Growth Rate (2014-2018)
7.6.4. Argentina
7.6.4.1. Argentina Cancer Biological Therapy Revenue (Millions USD) and Growth Rate (2014-2018)
7.6.5. Columbia
7.6.5.1. Columbia Cancer Biological Therapy Revenue (Millions USD) and Growth Rate (2014-2018)
7.6.6. Rest of South America
7.6.6.1. Rest of South America Cancer Biological Therapy Revenue (Millions USD) and Growth Rate (2014-2018)
7.7. Middle East and Africa Cancer Biological Therapy by Countries
7.7.1. Middle East and Africa Cancer Biological Therapy Revenue and Growth Rate (2014-2018)
7.7.2. Middle East and Africa Cancer Biological Therapy Revenue (Million USD) by Countries (2014-2018)
7.7.3. Saudi Arabia
7.7.3.1. Saudi Arabia Cancer Biological Therapy Revenue (Millions USD) and Growth Rate (2014-2018)
7.7.4. United Arab Emirates
7.7.4.1. United Arab Emirates Cancer Biological Therapy Revenue (Millions USD) and Growth Rate (2014-2018)
7.7.5. Egypt
7.7.5.1. Egypt Cancer Biological Therapy Revenue (Millions USD) and Growth Rate (2014-2018)
7.7.6. Nigeria
7.7.6.1. Nigeria Cancer Biological Therapy Revenue (Millions USD) and Growth Rate (2014-2018)
7.7.7. South Africa
7.7.7.1. South Africa Cancer Biological Therapy Revenue (Millions USD) and Growth Rate (2014-2018)
7.7.8. Turkey
7.7.8.1. Turkey Cancer Biological Therapy Revenue (Millions USD) and Growth Rate (2014-2018)
7.7.9. Rest of Middle East and Africa
7.7.9.1. Rest of Middle East and Africa Cancer Biological Therapy Revenue (Millions USD) and Growth Rate (2014-2018)
8. Company Profiles
8.1. Bristol-Myers Squibb
8.1.1. Business Overview
8.1.2. Service Portfolio
8.1.3. Strategic Developments
8.1.4. Revenue and Market Share
8.2. F. Hoffmann-La Roche AG
8.2.1. Business Overview
8.2.2. Service Portfolio
8.2.3. Strategic Developments
8.2.4. Revenue and Market Share
8.3. Merck & Co Inc
8.3.1. Business Overview
8.3.2. Service Portfolio
8.3.3. Strategic Developments
8.3.4. Revenue and Market Share
8.4. Eli Lilly
8.4.1. Business Overview
8.4.2. Service Portfolio
8.4.3. Strategic Developments
8.4.4. Revenue and Market Share
8.5. Seattle Genetics, Inc
8.5.1. Business Overview
8.5.2. Service Portfolio
8.5.3. Strategic Developments
8.5.4. Revenue and Market Share
8.6. Amgen Inc
8.6.1. Business Overview
8.6.2. Service Portfolio
8.6.3. Strategic Developments
8.6.4. Revenue and Market Share
8.7. Celgene Corporation
8.7.1. Business Overview
8.7.2. Service Portfolio
8.7.3. Strategic Developments
8.7.4. Revenue and Market Share
8.8. Novartis International AG
8.8.1. Business Overview
8.8.2. Service Portfolio
8.8.3. Strategic Developments
8.8.4. Revenue and Market Share
8.9. GlaxoSmithKline Plc
8.9.1. Business Overview
8.9.2. Service Portfolio
8.9.3. Strategic Developments
8.9.4. Revenue and Market Share
8.10. Spectrum Pharmaceuticals, Inc
8.10.1. Business Overview
8.10.2. Service Portfolio
8.10.3. Strategic Developments
8.10.4. Revenue and Market Share
9. Global Cancer Biological Therapy Market Competition, by Manufacturer
9.1. Global Cancer Biological Therapy Revenue and Market Share by Manufacturer (2016-2017)
9.2. Global Cancer Biological Therapy Price By Region (2016-2017)
9.3. Top 5 Cancer Biological Therapy Manufacturer Market Share
9.4. Market Competition Trend
10. Cancer Biological Therapy Market Forecast (2018-2025)
10.1. Global Cancer Biological Therapy Revenue (Millions USD) and Growth Rate (2018-2025)
10.2. Cancer Biological Therapy Market Forecast by Regions (2018-2025)
10.2.1. North America Cancer Biological Therapy Market Forecast (2018-2025)
10.2.1.1. United States Cancer Biological Therapy Market Forecast (2018-2025)
10.2.1.2. Canada Cancer Biological Therapy Market Forecast (2018-2025)
10.2.1.3. Mexico Cancer Biological Therapy Market Forecast (2018-2025)
10.2.2. Europe Cancer Biological Therapy Market Forecast (2018-2025)
10.2.2.1. Germany Cancer Biological Therapy Market Forecast (2018-2025)
10.2.2.2. France Cancer Biological Therapy Market Forecast (2018-2025)
10.2.2.3. UK Cancer Biological Therapy Market Forecast (2018-2025)
10.2.2.4. Russia Cancer Biological Therapy Market Forecast (2018-2025)
10.2.2.5. Italy Cancer Biological Therapy Market Forecast (2018-2025)
10.2.2.6. Rest of Europe Cancer Biological Therapy Market Forecast (2018-2025)
10.2.3. Asia-Pacific Cancer Biological Therapy Market Forecast (2018-2025)
10.2.3.1. China Cancer Biological Therapy Market Forecast (2018-2025)
10.2.3.2. Japan Cancer Biological Therapy Market Forecast (2018-2025)
10.2.3.3. Korea Cancer Biological Therapy Market Forecast (2018-2025)
10.2.3.4. India Cancer Biological Therapy Market Forecast (2018-2025)
10.2.3.5. Southeast Asia Cancer Biological Therapy Market Forecast (2018-2025)
10.2.3.6. Rest of Asia-Pacific Cancer Biological Therapy Market Forecast (2018-2025)
10.2.4. South America Cancer Biological Therapy Market Forecast (2018-2025)
10.2.4.1. Brazil Cancer Biological Therapy Market Forecast (2018-2025)
10.2.4.2. Argentina Cancer Biological Therapy Market Forecast (2018-2025)
10.2.4.3. Columbia Cancer Biological Therapy Market Forecast (2018-2025)
10.2.4.4. Rest of South America Cancer Biological Therapy Market Forecast (2018-2025)
10.2.5. Middle East and Africa Cancer Biological Therapy Market Forecast (2018-2025)
10.2.5.1. Saudi Arabia Cancer Biological Therapy Market Forecast (2018-2025)
10.2.5.2. United Arab Emirates Cancer Biological Therapy Market Forecast (2018-2025)
10.2.5.3. Egypt Cancer Biological Therapy Market Forecast (2018-2025)
10.2.5.4. Nigeria Cancer Biological Therapy Market Forecast (2018-2025)
10.2.5.5. South Africa Cancer Biological Therapy Market Forecast (2018-2025)
10.2.5.6. Turkey Cancer Biological Therapy Market Forecast (2018-2025)
10.2.5.7. Rest of Middle East and Africa Cancer Biological Therapy Market Forecast (2018-2025)
10.3. Cancer Biological Therapy Market Forecast by Product Type (2018-2025)
10.3.1. Cancer Biological Therapy Forecast by Product Type (2018-2025)
10.3.2. Cancer Biological Therapy Market Share Forecast by Product Type (2018-2025)
10.4. Cancer Biological Therapy Market Forecast by Distribution Channel (2018-2025)
10.4.1. Cancer Biological Therapy Forecast by Distribution Channel (2018-2025)
10.4.2. Cancer Biological Therapy Market Share Forecast by Distribution Channel (2018-2025)
Figure United States Cancer Biological Therapy Revenue (Million USD) and Growth Rate (2014-2025)
Figure Canada Cancer Biological Therapy Revenue (Million USD) and Growth Rate (2014-2025)
Figure Mexico Cancer Biological Therapy Revenue (Million USD) and Growth Rate (2014-2025)
Figure Germany Cancer Biological Therapy Revenue (Million USD) and Growth Rate (2014-2025)
Figure France Cancer Biological Therapy Revenue (Million USD) and Growth Rate (2014-2025)
Figure UK Cancer Biological Therapy Revenue (Million USD) and Growth Rate (2014-2025)
Figure Russia Cancer Biological Therapy Revenue (Million USD) and Growth Rate (2014-2025)
Figure Italy Cancer Biological Therapy Revenue (Million USD) and Growth Rate (2014-2025)
Figure Rest of Europe Cancer Biological Therapy Revenue (Million USD) and Growth Rate (2014-2025)
Figure China Cancer Biological Therapy Revenue (Million USD) and Growth Rate (2014-2025)
Figure Japan Cancer Biological Therapy Revenue (Million USD) and Growth Rate (2014-2025)
Figure Korea Cancer Biological Therapy Revenue (Million USD) and Growth Rate (2014-2025)
Figure India Cancer Biological Therapy Revenue (Million USD) and Growth Rate (2014-2025)
Figure Southeast Asia Cancer Biological Therapy Revenue (Million USD) and Growth Rate (2014-2025)
Figure Rest of Asia-Pacific Cancer Biological Therapy Revenue (Million USD) and Growth Rate (2014-2025)
Figure Brazil Cancer Biological Therapy Revenue (Million USD) and Growth Rate (2014-2025)
Figure Argentina Cancer Biological Therapy Revenue (Million USD) and Growth Rate (2014-2025)
Figure Columbia Cancer Biological Therapy Revenue (Million USD) and Growth Rate (2014-2025)
Figure Rest of South America Cancer Biological Therapy Revenue (Million USD) and Growth Rate (2014-2025)
Figure Saudi Arabia Cancer Biological Therapy Revenue (Million USD) and Growth Rate (2014-2025)
Figure United Arab Emirates Cancer Biological Therapy Revenue (Million USD) and Growth Rate (2014-2025)
Figure Egypt Cancer Biological Therapy Revenue (Million USD) and Growth Rate (2014-2025)
Figure Nigeria Cancer Biological Therapy Revenue (Million USD) and Growth Rate (2014-2025)
Figure South Africa Cancer Biological Therapy Revenue (Million USD) and Growth Rate (2014-2025)
Figure Turkey Cancer Biological Therapy Revenue (Million USD) and Growth Rate (2014-2025)
Figure Rest of Middle East and Africa Cancer Biological Therapy Revenue (Million USD) and Growth Rate (2014-2025)
Table Global Cancer Biological Therapy Revenue and Revenue Share by Product Type (2014-2018)
Figure Global Cancer growth blockers Revenue and Growth Rate (2014-2018)
Figure Global Cytokines Revenue and Growth Rate (2014-2018)
Figure Global Gene therapy Revenue and Growth Rate (2014-2018)
Figure Global Vaccines Revenue and Growth Rate (2014-2018)
Figure Global Monoclonal antibodies Revenue and Growth Rate (2014-2018)
Figure Global Blood cell growth factors Revenue and Growth Rate (2014-2018)
Table Global Cancer Biological Therapy Revenue and Revenue Share by Distribution Channel (2014-2018)
Figure Global Retail pharmacies Revenue and Growth Rate (2014-2018)
Figure Global Hospital pharmacies Revenue and Growth Rate (2014-2018)
Figure Global Mail order pharmacies Revenue and Growth Rate (2014-2018)
Table Global Cancer Biological Therapy Revenue by Regions (2014-2018)
Figure North America Cancer Biological Therapy Growth Rate (2014-2018)
Figure North America Cancer Biological Therapy Revenue and Growth Rate (2014-2018)
Figure North America Cancer Biological Therapy by Countries (2014-2018)
Figure North America Cancer Biological Therapy Revenue (Million USD) by Countries (2014-2018)
Figure United States Cancer Biological Therapy Growth Rate (2014-2018)
Figure United States Cancer Biological Therapy Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Canada Cancer Biological Therapy Growth Rate (2014-2018)
Figure Canada Cancer Biological Therapy Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Mexico Cancer Biological Therapy Growth Rate (2014-2018)
Figure Mexico Cancer Biological Therapy Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Europe Cancer Biological Therapy Growth Rate (2014-2018)
Figure Europe Cancer Biological Therapy Revenue and Growth Rate (2014-2018)
Figure Europe Cancer Biological Therapy by Countries (2014-2018)
Figure Europe Cancer Biological Therapy Revenue (Million USD) by Countries (2014-2018)
Figure Germany Cancer Biological Therapy Growth Rate (2014-2018)
Figure Germany Cancer Biological Therapy Revenue (Millions USD) and Growth Rate (2014-2018)
Figure France Cancer Biological Therapy Growth Rate (2014-2018)
Figure France Cancer Biological Therapy Revenue (Millions USD) and Growth Rate (2014-2018)
Figure UK Cancer Biological Therapy Growth Rate (2014-2018)
Figure UK Cancer Biological Therapy Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Russia Cancer Biological Therapy Growth Rate (2014-2018)
Figure Russia Cancer Biological Therapy Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Italy Cancer Biological Therapy Growth Rate (2014-2018)
Figure Italy Cancer Biological Therapy Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Rest of Europe Cancer Biological Therapy Growth Rate (2014-2018)
Figure Rest of Europe Cancer Biological Therapy Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Asia-Pacific Cancer Biological Therapy Growth Rate (2014-2018)
Figure Asia-Pacific Cancer Biological Therapy Revenue and Growth Rate (2014-2018)
Figure Asia-Pacific Cancer Biological Therapy by Countries (2014-2018)
Figure Asia-Pacific Cancer Biological Therapy Revenue (Million USD) by Countries (2014-2018)
Figure China Cancer Biological Therapy Growth Rate (2014-2018)
Figure China Cancer Biological Therapy Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Japan Cancer Biological Therapy Growth Rate (2014-2018)
Figure Japan Cancer Biological Therapy Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Korea Cancer Biological Therapy Growth Rate (2014-2018)
Figure Korea Cancer Biological Therapy Revenue (Millions USD) and Growth Rate (2014-2018)
Figure India Cancer Biological Therapy Growth Rate (2014-2018)
Figure India Cancer Biological Therapy Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Southeast Asia Cancer Biological Therapy Growth Rate (2014-2018)
Figure Southeast Asia Cancer Biological Therapy Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Rest of Asia-Pacific Cancer Biological Therapy Growth Rate (2014-2018)
Figure Rest of Asia-Pacific Cancer Biological Therapy Revenue (Millions USD) and Growth Rate (2014-2018)
Figure South America Cancer Biological Therapy Growth Rate (2014-2018)
Figure South America Cancer Biological Therapy Revenue and Growth Rate (2014-2018)
Figure South America Cancer Biological Therapy by Countries (2014-2018)
Figure South America Cancer Biological Therapy Revenue (Million USD) by Countries (2014-2018)
Figure Brazil Cancer Biological Therapy Growth Rate (2014-2018)
Figure Brazil Cancer Biological Therapy Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Argentina Cancer Biological Therapy Growth Rate (2014-2018)
Figure Argentina Cancer Biological Therapy Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Columbia Cancer Biological Therapy Growth Rate (2014-2018)
Figure Columbia Cancer Biological Therapy Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Rest of South America Cancer Biological Therapy Growth Rate (2014-2018)
Figure Rest of South America Cancer Biological Therapy Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Middle East and Africa Cancer Biological Therapy Growth Rate (2014-2018)
Figure Middle East and Africa Cancer Biological Therapy Revenue and Growth Rate (2014-2018)
Figure Middle East and Africa Cancer Biological Therapy by Countries (2014-2018)
Figure Middle East and Africa Cancer Biological Therapy Revenue (Million USD) by Countries (2014-2018)
Figure Saudi Arabia Cancer Biological Therapy Growth Rate (2014-2018)
Figure Saudi Arabia Cancer Biological Therapy Revenue (Millions USD) and Growth Rate (2014-2018)
Figure United Arab Emirates Cancer Biological Therapy Growth Rate (2014-2018)
Figure United Arab Emirates Cancer Biological Therapy Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Egypt Cancer Biological Therapy Growth Rate (2014-2018)
Figure Egypt Cancer Biological Therapy Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Nigeria Cancer Biological Therapy Growth Rate (2014-2018)
Figure Nigeria Cancer Biological Therapy Revenue (Millions USD) and Growth Rate (2014-2018)
Figure South Africa Cancer Biological Therapy Growth Rate (2014-2018)
Figure South Africa Cancer Biological Therapy Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Turkey Cancer Biological Therapy Growth Rate (2014-2018)
Figure Turkey Cancer Biological Therapy Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Rest of Middle East and Africa Cancer Biological Therapy Growth Rate (2014-2018)
Figure Rest of Middle East and Africa Cancer Biological Therapy Revenue (Millions USD) and Growth Rate (2014-2018)
Table Bristol-Myers Squibb Cancer Biological Therapy Price, Revenue, Gross Margin and Market Share (2016-2017)
Table F. Hoffmann-La Roche AG Cancer Biological Therapy Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Merck & Co Inc Cancer Biological Therapy Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Eli Lilly Cancer Biological Therapy Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Seattle Genetics, Inc Cancer Biological Therapy Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Amgen Inc Cancer Biological Therapy Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Celgene Corporation Cancer Biological Therapy Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis International AG Cancer Biological Therapy Price, Revenue, Gross Margin and Market Share (2016-2017)
Table GlaxoSmithKline Plc Cancer Biological Therapy Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Spectrum Pharmaceuticals, Inc Cancer Biological Therapy Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Cancer Biological Therapy Market Share by Manufacturer
Figure Global Cancer Biological Therapy Revenue and Market Share by Manufacturer
Table Global Cancer Biological Therapy Price by Region (2016-2017)
Figure Top 5 Cancer Biological Therapy Manufacturer (Revenue) Market Share
Figure Market Competition Trend
Figure Global Cancer Biological Therapy Revenue (Millions USD) and Growth Rate (2018-2025)
Table Cancer Biological Therapy Market Forecast by Regions (2018-2025)
Figure North America Cancer Biological Therapy Market Forecast (2018-2025)
Figure United States Cancer Biological Therapy Market Forecast (2018-2025)
Figure Canada Cancer Biological Therapy Market Forecast (2018-2025)
Figure Mexico Cancer Biological Therapy Market Forecast (2018-2025)
Figure Europe Cancer Biological Therapy Market Forecast (2018-2025)
Figure Germany Cancer Biological Therapy Market Forecast (2018-2025)
Figure France Cancer Biological Therapy Market Forecast (2018-2025)
Figure UK Cancer Biological Therapy Market Forecast (2018-2025)
Figure Russia Cancer Biological Therapy Market Forecast (2018-2025)
Figure Italy Cancer Biological Therapy Market Forecast (2018-2025)
Figure Rest of Europe Cancer Biological Therapy Market Forecast (2018-2025)
Figure Asia-Pacific Cancer Biological Therapy Market Forecast (2018-2025)
Figure China Cancer Biological Therapy Market Forecast (2018-2025)
Figure Japan Cancer Biological Therapy Market Forecast (2018-2025)
Figure Korea Cancer Biological Therapy Market Forecast (2018-2025)
Figure India Cancer Biological Therapy Market Forecast (2018-2025)
Figure Southeast Asia Cancer Biological Therapy Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Cancer Biological Therapy Market Forecast (2018-2025)
Figure South America Cancer Biological Therapy Market Forecast (2018-2025)
Figure Brazil Cancer Biological Therapy Market Forecast (2018-2025)
Figure Argentina Cancer Biological Therapy Market Forecast (2018-2025)
Figure Columbia Cancer Biological Therapy Market Forecast (2018-2025)
Figure Rest of South America Cancer Biological Therapy Market Forecast (2018-2025)
Figure Middle East and Africa Cancer Biological Therapy Market Forecast (2018-2025)
Figure Saudi Arabia Cancer Biological Therapy Market Forecast (2018-2025)
Figure United Arab Emirates Cancer Biological Therapy Market Forecast (2018-2025)
Figure Egypt Cancer Biological Therapy Market Forecast (2018-2025)
Figure Nigeria Cancer Biological Therapy Market Forecast (2018-2025)
Figure South Africa Cancer Biological Therapy Market Forecast (2018-2025)
Figure Turkey Cancer Biological Therapy Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Cancer Biological Therapy Market Forecast (2018-2025)
Figure Global Cancer Biological Therapy Forecast by Product Type (2018-2025)
Figure Global Cancer Biological Therapy Market Share Forecast by Product Type (2018-2025)
Figure Global Cancer Biological Therapy Forecast by Product Type (2018-2025)
Figure Global Cancer Biological Therapy Forecast by Distribution Channel (2018-2025)
Figure Global Cancer Biological Therapy Market Share Forecast by Distribution Channel (2018-2025)
Figure Global Cancer Biological Therapy Forecast by Distribution Channel (2018-2025)
Please Note: Data related to the Companies are subject to Availability.
Similar Reports
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
- Publish Date: November 14, 2017
- $5370
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
- Publish Date: July 20, 2017
- $5370
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...
- Publish Date: April 24, 2017
- $5370
